Quoin Pharmaceuticals Statistics
Share Statistics
Quoin Pharmaceuticals has 588.17K
shares outstanding. The number of shares has increased by 135.73%
in one year.
Shares Outstanding | 588.17K |
Shares Change (YoY) | 135.73% |
Shares Change (QoQ) | 77.2% |
Owned by Institutions (%) | 0.03% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 296 |
FTD / Avg. Volume | 0.1% |
Short Selling Information
The latest short interest is 225.36K, so 38.32% of the outstanding
shares have been sold short.
Short Interest | 225.36K |
Short % of Shares Out | 38.32% |
Short % of Float | 1.18% |
Short Ratio (days to cover) | 1 |
Valuation Ratios
PE Ratio | 0 |
Forward PE | -0.63 |
PS Ratio | 0 |
Forward PS | 0.1 |
PB Ratio | 0 |
P/FCF Ratio | -0.01 |
PEG Ratio | 0 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Quoin Pharmaceuticals.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.57,
with a Debt / Equity ratio of 0.
Current Ratio | 3.57 |
Quick Ratio | 3.57 |
Debt / Equity | 0 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | $-2,987,490,666.67 |
Employee Count | 3 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | -8.95B |
Effective Tax Rate | 99.9% |
Stock Price Statistics
The stock price has increased by 1114.1% in the
last 52 weeks. The beta is 1.78, so Quoin Pharmaceuticals's
price volatility has been higher than the market average.
Beta | 1.78 |
52-Week Price Change | 1114.1% |
50-Day Moving Average | 7.48 |
200-Day Moving Average | 2.79 |
Relative Strength Index (RSI) | 61.84 |
Average Volume (20 Days) | 287,378 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -9.57M |
Net Income | -8.96B |
EBITDA | -8.9M |
EBIT | -9.01M |
Earnings Per Share (EPS) | -1911.5 |
Full Income Statement Balance Sheet
The company has 3.62M in cash and 0 in
debt, giving a net cash position of 3.62M.
Cash & Cash Equivalents | 3.62M |
Total Debt | n/a |
Net Cash | n/a |
Retained Earnings | -55.17B |
Total Assets | 12.96M |
Working Capital | 7.64M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -7.89M
and capital expenditures 0, giving a free cash flow of -7.86M.
Operating Cash Flow | -7.89M |
Capital Expenditures | n/a |
Free Cash Flow | -7.86M |
FCF Per Share | -58.65 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |